Aarti Pharmalabs Q2 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
826.90
1.90 (0.23%)
1.90 (0.23%)Volume20.52 K
Updated: Fri 11 Sep, 2026 | 15:26:23
NSE
826.951.20 (0.15%)
1.20 (0.15%)Volume2.69 L
Updated: Fri 11 Sep, 2026 | 15:54:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Aarti Pharmalabs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 368.39 | 433.18 | 17.42% | 385.24 | -4.37% |
| Depreciation/ Amortization | 24.77 | 30.03 | 8.67% | 20.88 | 18.61% |
| Operating Income | 49.95 | 102.62 | -31.06% | 72.79 | -31.38% |
| Net Income | 27.92 | 76.14 | -43.59% | 54.62 | -48.88% |
| Other Operating Expenses Total | 90.43 | 116.23 | 12.63% | 91.05 | -0.68% |
| Net Income Before Taxes | 38.69 | 101.06 | -40.89% | 71.77 | -46.09% |
| Total Revenue | 418.33 | 535.80 | 8.32% | 458.03 | -8.67% |
| Selling/ General/ Admin Expenses Total | 43.41 | 50.32 | 5.22% | 37.73 | 15.06% |
| Diluted Normalized EPS | 3.08 | 8.39 | -43.59% | 6.02 | -48.84% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.